Objective: To explore patient factors that influence patients' decisions about Neoadjuvant chemotherapy (NC) including patient unmet needs, challenges in decision making, and the role of family and caregiver involvement in treatment decision making. Our goal is to elucidate patient factors including their beliefs, values, expectations, worries about NC and MIBC, emotional challenges, and the importance of caregivers' involvement in decision making and selection of treatment procedures. Design: A qualitative study with semi-structured single interviews and focus groups. Atlas.ti software was used to analyze the qualitative data collected. Settings: Icahn School of Medicine at Mount Sinai (ISMMS) and Northwell Health (NH), New York, USA. Meth...
Most men with low-risk prostate cancer have several treatment options. Since there is no clear evide...
Background: Patient engagement has become a common focus for healthcare organizations in the last de...
Item does not contain fulltextIn palliative cancer treatment, the choice between palliative chemothe...
Although approximately 75% of bladder cancers are non-muscle invasive (NMIBC) at diagnosis, most res...
Background: The incidence of prostate continues to increase but due to the management strategies ava...
Objectives: Investigating supportive care (SC) needs and utilization/willingness to use SC services ...
Objective: To determine patient experience and perception following a diagnosis of non-muscle-invasi...
Objectives: To explore patient views on participation in treatment, physical care and psychological ...
Background: Little is known about the unmet supportive care needs of patients affected by muscle inv...
Patients being treated for bladder cancer share issues in common with other cancer patients, but als...
Purpose: Bladder cancer (BC) is a common disease with disparate treatment options and variable outco...
Contains fulltext : 95653.pdf (publisher's version ) (Open Access)BACKGROUND: Ther...
Introduction:This study explores patient preferences for involvement in lung cancer treatment decisi...
PurposeWe evaluated the survival of patients with muscle invasive bladder cancer undergoing radical ...
Men diagnosed with early stage prostate cancer face multiple treatment options, each with distinctiv...
Most men with low-risk prostate cancer have several treatment options. Since there is no clear evide...
Background: Patient engagement has become a common focus for healthcare organizations in the last de...
Item does not contain fulltextIn palliative cancer treatment, the choice between palliative chemothe...
Although approximately 75% of bladder cancers are non-muscle invasive (NMIBC) at diagnosis, most res...
Background: The incidence of prostate continues to increase but due to the management strategies ava...
Objectives: Investigating supportive care (SC) needs and utilization/willingness to use SC services ...
Objective: To determine patient experience and perception following a diagnosis of non-muscle-invasi...
Objectives: To explore patient views on participation in treatment, physical care and psychological ...
Background: Little is known about the unmet supportive care needs of patients affected by muscle inv...
Patients being treated for bladder cancer share issues in common with other cancer patients, but als...
Purpose: Bladder cancer (BC) is a common disease with disparate treatment options and variable outco...
Contains fulltext : 95653.pdf (publisher's version ) (Open Access)BACKGROUND: Ther...
Introduction:This study explores patient preferences for involvement in lung cancer treatment decisi...
PurposeWe evaluated the survival of patients with muscle invasive bladder cancer undergoing radical ...
Men diagnosed with early stage prostate cancer face multiple treatment options, each with distinctiv...
Most men with low-risk prostate cancer have several treatment options. Since there is no clear evide...
Background: Patient engagement has become a common focus for healthcare organizations in the last de...
Item does not contain fulltextIn palliative cancer treatment, the choice between palliative chemothe...